178 related articles for article (PubMed ID: 19365815)
1. Crystal and molecular structure of beta-cyclodextrins functionalized with the anti-inflammatory drug Etodolac.
Puglisi A; Rizzarelli E; Vecchio G; Iacovino R; Benedetti E; Pedone C; Saviano M
Biopolymers; 2009 Dec; 91(12):1227-35. PubMed ID: 19365815
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 6-mono-6-deoxy-beta-cyclodextrins substituted with isomeric aminobenzoic acids. Structural characterization, conformational preferences, and self-inclusion as studied by NMR spectroscopy in aqueous solution and by X-ray crystallography in the solid state.
Eliadou K; Giastas P; Yannakopoulou K; Mavridis IM
J Org Chem; 2003 Oct; 68(22):8550-7. PubMed ID: 14575485
[TBL] [Abstract][Full Text] [Related]
3. Crystal form III of beta-cyclodextrin-ethanol inclusion complex: layer-type structure with dimeric motif.
Aree T; Chaichit N
Carbohydr Res; 2008 Sep; 343(13):2285-91. PubMed ID: 18490008
[TBL] [Abstract][Full Text] [Related]
4. Regioselective synthesis of cyclodextrin mono-substituted conjugates of non-steroidal anti-inflammatory drugs at C-2 secondary hydroxyl by protease in non-aqueous media.
Wang N; Wu Q; Xiao YM; Chen CX; Lin XF
Bioorg Med Chem; 2005 Jun; 13(11):3667-71. PubMed ID: 15862995
[TBL] [Abstract][Full Text] [Related]
5. Molecular electrostatic potentials and hydrogen bonding in alpha-, beta-, and gamma-cyclodextrins.
Pinjari RV; Joshi KA; Gejji SP
J Phys Chem A; 2006 Dec; 110(48):13073-80. PubMed ID: 17134168
[TBL] [Abstract][Full Text] [Related]
6. Determination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxypropyl)-beta-cyclodextrin.
Dung PT; Ko MY; Choi HJ; Sin KS; Kim KH
Arch Pharm Res; 2008 Sep; 31(9):1218-23. PubMed ID: 18806967
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the supramolecular linear polymer formed by the self-assembly of mono-6-deoxy-6-adamantylamide-beta-cyclodextrin.
Tellini VH; Jover A; Galantini L; Meijide F; Tato JV
Acta Crystallogr B; 2004 Apr; 60(Pt 2):204-10. PubMed ID: 15017094
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Yang ZX; Chen Y; Liu Y
Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives.
Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438
[TBL] [Abstract][Full Text] [Related]
10. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
11. Structure and intramolecular flexibility of beta-cyclodextrin complex with (-)-epigallocatechin gallate in aqueous solvent.
Ishizu T; Hirata C; Yamamoto H; Harano K
Magn Reson Chem; 2006 Aug; 44(8):776-83. PubMed ID: 16705621
[TBL] [Abstract][Full Text] [Related]
12. Host-guest complexation of oxicam NSAIDs with beta-cyclodextrin.
Banerjee R; Chakraborty H; Sarkar M
Biopolymers; 2004 Nov; 75(4):355-65. PubMed ID: 15372483
[TBL] [Abstract][Full Text] [Related]
13. X-ray crystallography and solution NMR spectroscopy characterization of heptakis(2,3-di-O-acetyl-6-bromo-6-deoxy)cyclomaltoheptaose.
Giastas P; Eliadou K; Plyta ZF; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2004 Apr; 339(6):1189-94. PubMed ID: 15063210
[TBL] [Abstract][Full Text] [Related]
14. The molecular crystal structure and self-assembly behavior of 6(I)-O-(3-nitrophenyl)cyclomaltoheptaose.
Fan Z; Jing ZL; Diao CH
Carbohydr Res; 2005 Feb; 340(3):513-7. PubMed ID: 15680609
[TBL] [Abstract][Full Text] [Related]
15. Configurational studies of complexes of tea catechins with caffeine and various cyclodextrins.
Ishizu T; Kajitani S; Tsutsumi H; Sato T; Yamamoto H; Hirata C
Planta Med; 2011 Jul; 77(11):1099-109. PubMed ID: 21472646
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling study of beta-cyclodextrin complexes with (+)-catechin and (-)-epicatechin.
Yan C; Xiu Z; Li X; Hao C
J Mol Graph Model; 2007 Sep; 26(2):420-8. PubMed ID: 17320441
[TBL] [Abstract][Full Text] [Related]
17. Optimal configurations of "capped" beta-cyclodextrin dimers in water maximise hydrophobic association.
Gamieldien MR; Maestre I; Jaime C; Naidoo KJ
Chemphyschem; 2010 Feb; 11(2):452-9. PubMed ID: 20014087
[TBL] [Abstract][Full Text] [Related]
18. Novel behavior of O-methylated beta-cyclodextrins in inclusion of meso-tetraarylporphyrins.
Kano K; Nishiyabu R; Doi R
J Org Chem; 2005 Apr; 70(9):3667-73. PubMed ID: 15845005
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
